Značaj hormonske terapije u menopauzi

Originalni rad

Miodrag Savović

69–71

https://doi.org/10.5937/medrec2203069S

Apstrakt

Produžetkom životnog veka, produžava se i period menopauze, životnog doba koje nosi važne promene u funkcionisanju žene. Sagledavanje i prepoznavanje zdravstvenih problema i poboljšanje kvaliteta života izazovi su sa kojima se suočavaju i zdravstveni sistem i same pacijentkinje. Poseban izazov je pomoć onim ženama koje ulaze u menopauzu jatrogenim putem (npr. zbog bolesti ili operacije). Hormonska supstituciona terapija treba da bude proverena, dobro izabrana, efikasna i bezbedna, uz nadzor i konsultacije sa drugim specijalistima. Njena efikasnost naročito je prisutna kod žena do 10 godina od početka menopauze. Hormonska terapija može se primeniti oralno, intravaginalno, intrauterino i transdermalno.

Ključne reči: menopauza, rizici, hormonska suptsituciona terapija

Ceo tekst 

Literatura

  1. UCLA Obstetrics and Gynecology. Menopause, symtoms, treatments, diagnosis. Dostupno na: http://obgyn.ucla.edu/menopause, Preuzeto 28. septembra 2017.
  2. Hurd WW, Amesse LS, Randolph JF Jr. Menopause. In: Berek JS, ed. Novak’s Gynecology. 13th edition. Philadelphia: Lippincott, Williams & Wilkins 2002: 1143-97.
  3. Skaznik-Wikiel ME, Traub ML, Santoro N. Menopause. In: Jameson JL, De Groot LJ, de Krester DM, et al, eds. Endocrinology: Adult and Pediatric. 7th ed. Philadelphia, PA: Elsevier Saunders; 2016: chap 135.
  4. Kurjak A. i suradnici. Ultrazvuk u ginekologiji i perinatologiji. Zagreb: Medicinska naklada; 2007. pp. 116-130.
  5. Gambacciani M, Monteleone P, Ciaponi M, Sacco A, Genazzani AR. Clinical usefulness of endometrial screening by ultrasound in asymptomatic postmenopausal women. Maturitas. 2004; 48(4): 421-4.
  6. Lobo R. Menopause and care of the mature woman. In: Lentz GM, Lobo RA, Gershenson DM, Katz VL, eds. Comprehensive Gynecology. 6th ed. Philadelphia, PA. Elsevier Mosby; 2012: chap 14.
  7. ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014; 123(1): 202-16.
  8. Moyer VA; U.S. Preventive Services Task Force. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013; 158(9): 691-6.
  9. Brunner RL, Aragaki A, Barnabei V, Cochrane BB, Gass M, Hendrix S, et al. Menopausal symptom experience before and after stopping estrogen therapy in the Women’s Health Initiative randomized, placebo-controlled trial. Menopause. 2010; 17(5): 946-54.
  10. Furness S, Roberts H, Marjoribanks J, Lethaby A, Hickey M, Farquhar C. Hormone therapyin postmenopausal women and risk of endometrial hyperplasia. Cochrane Database SystRev 2009; 2: CD000402
  11. MacLennan AH, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogentherapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004; 4: CD002978.
  12. Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, et al. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol. 2009; 10: 135-46.